{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mortalité périnatale : Questions médicales les plus fréquentes",
"headline": "Mortalité périnatale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mortalité périnatale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-02",
"dateModified": "2025-03-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mortalité périnatale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mortalité infantile",
"url": "https://questionsmedicales.fr/mesh/D007226",
"about": {
"@type": "MedicalCondition",
"name": "Mortalité infantile",
"code": {
"@type": "MedicalCode",
"code": "D007226",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.550.475"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Mortalité périnatale",
"alternateName": "Perinatal Mortality",
"code": {
"@type": "MedicalCode",
"code": "D054238",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Keelin O'Donoghue",
"url": "https://questionsmedicales.fr/author/Keelin%20O%27Donoghue",
"affiliation": {
"@type": "Organization",
"name": "Pregnancy Loss Research Group (PLRG), Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland."
}
},
{
"@type": "Person",
"name": "Richard Greene",
"url": "https://questionsmedicales.fr/author/Richard%20Greene",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynaecology, School of Medicine and Health, University College Cork, Cork, Ireland."
}
},
{
"@type": "Person",
"name": "Sara Leitao",
"url": "https://questionsmedicales.fr/author/Sara%20Leitao",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynaecology, School of Medicine and Health, University College Cork, Cork, Ireland."
}
},
{
"@type": "Person",
"name": "K S Joseph",
"url": "https://questionsmedicales.fr/author/K%20S%20Joseph",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynaecology, School of Population and Public Health, University of British Columbia and the Children's and Women's Hospital and Health Centre of British Columbia, Vancouver, British Columbia, Canada."
}
},
{
"@type": "Person",
"name": "Alfred Körblein",
"url": "https://questionsmedicales.fr/author/Alfred%20K%C3%B6rblein",
"affiliation": {
"@type": "Organization",
"name": "Untere Söldnersgasse 8, D-90403, Nürnberg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation.",
"datePublished": "2023-01-20",
"url": "https://questionsmedicales.fr/article/36599813",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ejh.13925"
}
},
{
"@type": "ScholarlyArticle",
"name": "Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review.",
"datePublished": "2022-12-01",
"url": "https://questionsmedicales.fr/article/36454598",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/vox.13387"
}
},
{
"@type": "ScholarlyArticle",
"name": "The safety of ABO minor incompatible platelets transfusions using a rapid infuser.",
"datePublished": "2024-02-01",
"url": "https://questionsmedicales.fr/article/38299721",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/trf.17739"
}
},
{
"@type": "ScholarlyArticle",
"name": "Therapeutic Efficacy of Platelet Transfusion and Analysis of Influencing Factors in 364 patients.",
"datePublished": "2023-02-09",
"url": "https://questionsmedicales.fr/article/36758527",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000529542"
}
},
{
"@type": "ScholarlyArticle",
"name": "Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit.",
"datePublished": "2022-11-12",
"url": "https://questionsmedicales.fr/article/36369934",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/trf.17184"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Collecte de données",
"item": "https://questionsmedicales.fr/mesh/D003625"
},
{
"@type": "ListItem",
"position": 6,
"name": "Registre civil",
"item": "https://questionsmedicales.fr/mesh/D014798"
},
{
"@type": "ListItem",
"position": 7,
"name": "Mortalité",
"item": "https://questionsmedicales.fr/mesh/D009026"
},
{
"@type": "ListItem",
"position": 8,
"name": "Mortalité infantile",
"item": "https://questionsmedicales.fr/mesh/D007226"
},
{
"@type": "ListItem",
"position": 9,
"name": "Mortalité périnatale",
"item": "https://questionsmedicales.fr/mesh/D054238"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mortalité périnatale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mortalité périnatale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mortalité périnatale",
"description": "Comment diagnostiquer la mortalité périnatale ?\nQuels examens sont nécessaires pour évaluer la mortalité périnatale ?\nQuels indicateurs sont utilisés pour évaluer la mortalité périnatale ?\nComment les données de mortalité périnatale sont-elles collectées ?\nQuel rôle joue l'autopsie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mortalité périnatale",
"description": "Quels sont les symptômes associés à la mortalité périnatale ?\nComment reconnaître un décès fœtal in utero ?\nQuels signes peuvent indiquer une complication périnatale ?\nQuels sont les signes cliniques d'un nouveau-né décédé ?\nComment évaluer la santé d'un nouveau-né à risque ?",
"url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mortalité périnatale",
"description": "Quelles mesures préventives peuvent réduire la mortalité périnatale ?\nComment l'éducation prénatale aide-t-elle à prévenir la mortalité périnatale ?\nQuel rôle joue le suivi médical dans la prévention ?\nComment la vaccination peut-elle influencer la mortalité périnatale ?\nPourquoi est-il important de gérer les maladies maternelles ?",
"url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mortalité périnatale",
"description": "Quels traitements sont disponibles pour prévenir la mortalité périnatale ?\nComment traiter une détresse néonatale ?\nQuels médicaments peuvent réduire les risques périnataux ?\nQuel rôle joue la césarienne dans la mortalité périnatale ?\nComment gérer les grossesses à risque ?",
"url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mortalité périnatale",
"description": "Quelles sont les complications courantes liées à la mortalité périnatale ?\nComment les anomalies congénitales affectent-elles la mortalité périnatale ?\nQuel impact a l'hypoxie sur le fœtus ?\nComment les infections maternelles influencent-elles la mortalité périnatale ?\nQuelles sont les conséquences d'une prématurité sur la mortalité périnatale ?",
"url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mortalité périnatale",
"description": "Quels sont les principaux facteurs de risque de mortalité périnatale ?\nComment le tabagisme affecte-t-il la mortalité périnatale ?\nQuel rôle joue la nutrition maternelle dans la mortalité périnatale ?\nComment les antécédents médicaux influencent-ils les risques ?\nQuel impact a l'accès aux soins prénatals sur la mortalité périnatale ?",
"url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la mortalité périnatale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'analyse des certificats de décès et des dossiers médicaux."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour évaluer la mortalité périnatale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échographies, des analyses sanguines et des examens post-mortem peuvent être requis."
}
},
{
"@type": "Question",
"name": "Quels indicateurs sont utilisés pour évaluer la mortalité périnatale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les taux de mortalité, les causes de décès et les facteurs de risque sont des indicateurs clés."
}
},
{
"@type": "Question",
"name": "Comment les données de mortalité périnatale sont-elles collectées ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont collectées par les systèmes de santé publique et les registres de décès."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'autopsie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'autopsie peut aider à déterminer la cause de décès et à identifier des anomalies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes associés à la mortalité périnatale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'absence de battements cardiaques fœtaux et des signes de détresse néonatale."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un décès fœtal in utero ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'absence de mouvements fœtaux et l'absence de battements cardiaques à l'échographie sont des signes."
}
},
{
"@type": "Question",
"name": "Quels signes peuvent indiquer une complication périnatale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements vaginaux, des douleurs abdominales ou une diminution des mouvements fœtaux peuvent indiquer des complications."
}
},
{
"@type": "Question",
"name": "Quels sont les signes cliniques d'un nouveau-né décédé ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une pâleur, une rigidité cadavérique et l'absence de respiration."
}
},
{
"@type": "Question",
"name": "Comment évaluer la santé d'un nouveau-né à risque ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation inclut l'examen physique, la surveillance des signes vitaux et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives peuvent réduire la mortalité périnatale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins prénatals réguliers, une nutrition adéquate et l'évitement de substances nocives sont essentiels."
}
},
{
"@type": "Question",
"name": "Comment l'éducation prénatale aide-t-elle à prévenir la mortalité périnatale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation prénatale informe les parents sur les soins et les signes de complications."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le suivi médical dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier permet de détecter et de traiter les problèmes de santé précocement."
}
},
{
"@type": "Question",
"name": "Comment la vaccination peut-elle influencer la mortalité périnatale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination des mères peut protéger les nouveau-nés contre certaines infections."
}
},
{
"@type": "Question",
"name": "Pourquoi est-il important de gérer les maladies maternelles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des maladies maternelles réduit les risques de complications pour le fœtus et le nouveau-né."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour prévenir la mortalité périnatale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des soins prénatals appropriés et la gestion des complications."
}
},
{
"@type": "Question",
"name": "Comment traiter une détresse néonatale ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure l'assistance respiratoire, la réanimation et des soins intensifs."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent réduire les risques périnataux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les corticostéroïdes peuvent aider à maturer les poumons fœtaux."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la césarienne dans la mortalité périnatale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La césarienne peut être nécessaire pour éviter des complications lors de l'accouchement."
}
},
{
"@type": "Question",
"name": "Comment gérer les grossesses à risque ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance accrue et des interventions médicales précoces sont essentielles pour les grossesses à risque."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications courantes liées à la mortalité périnatale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'hypoxie, les infections et les anomalies congénitales."
}
},
{
"@type": "Question",
"name": "Comment les anomalies congénitales affectent-elles la mortalité périnatale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anomalies congénitales peuvent entraîner des décès fœtaux ou néonatals en raison de malformations graves."
}
},
{
"@type": "Question",
"name": "Quel impact a l'hypoxie sur le fœtus ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypoxie peut provoquer des lésions cérébrales et augmenter le risque de mortalité périnatale."
}
},
{
"@type": "Question",
"name": "Comment les infections maternelles influencent-elles la mortalité périnatale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections maternelles peuvent se transmettre au fœtus et entraîner des complications graves."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une prématurité sur la mortalité périnatale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prématurité augmente le risque de complications et de décès néonatal en raison d'organes immatures."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de mortalité périnatale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge maternel avancé, les maladies chroniques et les grossesses multiples."
}
},
{
"@type": "Question",
"name": "Comment le tabagisme affecte-t-il la mortalité périnatale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme augmente le risque de complications et de décès fœtal en raison de l'hypoxie."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la nutrition maternelle dans la mortalité périnatale ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise nutrition peut entraîner des complications comme la prématurité et le faible poids à la naissance."
}
},
{
"@type": "Question",
"name": "Comment les antécédents médicaux influencent-ils les risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de complications obstétricales augmentent le risque de mortalité périnatale."
}
},
{
"@type": "Question",
"name": "Quel impact a l'accès aux soins prénatals sur la mortalité périnatale ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un accès limité aux soins prénatals augmente le risque de complications et de décès."
}
}
]
}
]
}
The delayed platelet engraftment associated with allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a common complication and often results in increased transplant-related complications...
Platelet transfusions are used across multiple patient populations to prevent and correct bleeding. This scoping review aimed to map the currently available systematic reviews (SRs) and evidence-based...
A systematic literature search was conducted in seven databases for SRs on effectiveness (including dose and timing, transfusion trigger and ratio to other blood products), production modalities and d...
We identified 110 SRs. The majority focused on clinical effectiveness, including prophylactic or therapeutic transfusions compared to no platelet transfusion (34 SRs), prophylactic compared to therape...
An interactive evidence map of SRs and evidence-based guidelines in the field of platelet transfusion has been developed and identified multiple reviews. This work serves as a tool for researchers loo...
Administering platelets through a rapid infuser is proven to be safe. However, the clinical significance of infusing ABO-incompatible platelets with red blood cells (RBCs) in a rapid infuser remains u...
Seven in vitro studies were performed including five cases (type A RBCs and type O platelets) and two controls (type A RBCs and platelets). Anti-A titers were measured in platelet units. An RBC unit a...
The post-mix DAT was positive for IgG in all test samples (5/5), and weakly positive for complement in 3/5. The changes in free Hb in test cases between measured and calculated post-mix spanned -2.2 t...
Our study suggested that mixing ABO-incompatible platelets with RBCs in a rapid infuser does not induce in vitro hemolysis. These findings support the use of rapid infusers regardless of platelet comp...
The aims of this study were to observe the therapeutic effect of platelet (PLT) transfusion and to analyze influencing factors for the sake of providing useful clues for improving the efficacy of PLT ...
Included in this study were patients who received PLT transfusion in the affiliated hospital of Nantong University. Patients' sex, age, height, weight, PLT transfusion status, and 20-24-h PLT count be...
A total of 364 patients received 1,060 PLT transfusions, including 728 successful transfusions and 332 unsuccessful transfusions. When the patients were grouped according to different etiologies, sign...
To reduce PTR, multiple factors should be considered comprehensively when PLT transfusion therapy is to be implemented in clinical practice. PLT antibody is the main immune factor causing PTR....
Following the results of the PlaNeT-2 randomized controlled trial showing decreased morbidity and mortality in neonates transfused at a threshold of 25 versus 50 × 10...
Prospective observational cohort chart-review study comparing all neonates consecutively admitted to the NICU during two 5-months periods: 2013 (before; N = 401) versus 2021 (after; N = 402). Possible...
Mean (± standard deviation) gestational age and birth weight were 34.9 ± 4.2 weeks and 2.5 ± 1.0 kg, respectively. In 2021, 5.0% were platelet-transfused versus 9.2% in 2013 (p = .027). Platelet trans...
Restrictive local transfusion thresholds in a NICU decreased the proportion of platelet-transfused neonates by 46% and reduced donor exposure in transfused patients....
Platelet transfusion refractoriness due to HLA alloimmunization presents a significant medical problem, particularly among multiply transfused patients with hematologic malignancies and those undergoi...
Assess mortality and neurodevelopmental outcomes at 2 years of corrected age in children who participated in the PlaNeT-2/MATISSE (Platelets for Neonatal Transfusion - 2/Management of Thrombocytopenia...
Randomised clinical trial, enrolling from June 2011 to August 2017. Follow-up was complete by January 2020. Caregivers were not blinded; however, outcome assessors were blinded to treatment group....
43 level II/III/IV neonatal intensive care units (NICUs) across UK, Netherlands and Ireland....
660 infants born at less than 34 weeks' gestation with platelet counts less than 50×10...
Infants were randomised to undergo a platelet transfusion at platelet count thresholds of 50×10...
Our prespecified long-term follow-up outcome was a composite of death or neurodevelopmental impairment (developmental delay, cerebral palsy, seizure disorder, profound hearing or vision loss) at 2 yea...
Follow-up data were available for 601 of 653 (92%) eligible participants. Of the 296 infants assigned to the higher threshold group, 147 (50%) died or survived with neurodevelopmental impairment, as c...
Infants randomised to a higher platelet transfusion threshold of 50×10...
ISRCTN87736839....
Transfusion-related acute lung injury (TRALI) is a severe complication of blood transfusion that is thought of as a two-hit event: first the underlying patient condition (e.g., sepsis), and then the t...
In a randomized controlled trial, 18 healthy male volunteers received a first hit of experimental endotoxemia (2 ng/kg lipopolysaccharide), and a second hit of fresh (2-day old) or aged (7-day old) au...
All subjects reacted adequately to lipopolysaccharide infusion and satisfied SIRS criteria (increased pulse [>90/min] and temperature [>38°C]). There were no differences between the saline, fresh, and...
In a human endotoxemia model of autologous platelet transfusion, with an adequate first hit and platelet storage lesion, transfusion of 7-day-old PC does not increase pulmonary inflammation compared w...
The short shelf-life of liquid-stored platelets (LP) at 20-24°C poses shortage and wastage challenges. Cryopreserved platelets have significantly extended shelf-life, and were safe and efficacious for...
We performed a phase 1b/2a randomized cross-over study comparing the safety and efficacy of cryopreserved buffy coat-derived pooled platelets (CP) to LP in the prophylactic transfusions of thrombocyto...
A total of 18 adults were randomly assigned 1:1 to CP and LP for their first thrombocytopenic period (TP) of up to 28-days. A total of 14 crossed over to the other platelet-arm for the second TP. Over...
During shortages, CP may supplement LP in prophylactic transfusions of thrombocytopenic patients....
We report Listeria monocytogenes infection in a patient in Italy who was transfused with pooled platelet concentrate. Genomic analysis revealed that L. monocytogenes isolates from the donor blood unit...